MedTrace Logo

Case Collection Study in the Evaluation of Doubling Time Rates in Non-Suspicious Breast Masses Using QT Ultrasound Technology

NCT03470051 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2021-03-18

No results posted yet for this study

Summary

This is a prospective case collection study to collect cases for subsequent statistical studies and future reader studies.

Conditions

  • Breast Fibroadenoma

Interventions

DIAGNOSTIC_TEST

QT Ultrasound

All subjects will be asked to agree to an ultrasound-guided breast needle biopsy by a qualified radiologist experienced in this procedure if not already completed prior to study entry.

Sponsors & Collaborators

  • QT Ultrasound LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-26
Primary Completion
2020-02-11
Completion
2020-02-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03470051 on ClinicalTrials.gov